Shopping Cart
Remove All
Your shopping cart is currently empty
Urabrelimab (SRF-231) is a humanized antibody targeting CD47, with antitumor activity. It blocks the CD47-SIRPα interaction and is used in studies of advanced malignant solid tumors.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $198 | In Stock | In Stock | |
| 5 mg | $579 | In Stock | In Stock | |
| 10 mg | $928 | - | In Stock | |
| 25 mg | $1,370 | - | In Stock | |
| 50 mg | $1,850 | - | In Stock |
| Description | Urabrelimab (SRF-231) is a humanized antibody targeting CD47, with antitumor activity. It blocks the CD47-SIRPα interaction and is used in studies of advanced malignant solid tumors. |
| In vitro | Urabrelimab specifically binds to human CD47 to induce phagocytosis in malignant B-cell lymphoma. Urabrelimab (10 μg/mL) induced tumor cell death in a CD32A-dependent manner. [1] |
| In vivo | Urabrelimab(100 μg, 3 times/week for 3 weeks) showed antitumor activity in a range of blood tumor xenotransplantation models. [1] |
| Synonyms | SRF-231, SRF231 |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Uniprot ID |
| Cas No. | 2249722-58-3 |
| Color | Transparent |
| Appearance | Liquid |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.